tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Bacterial Infections D001424 21 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Mouth Diseases D009059 5 associated lipids
Meningococcal Infections D008589 3 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Ruzicka T et al. Tacrolimus: the drug for the turn of the millennium? 1999 Arch Dermatol pmid:10328199
Laffitte E et al. Erosive pustular dermatosis of the scalp: treatment with topical tacrolimus. 2003 Arch Dermatol pmid:12810500
Chu J et al. Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid. 2003 Arch Dermatol pmid:12810523
Qureshi AA and Fischer MA Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risks. 2006 Arch Dermatol pmid:16702502
Thiers BH Topical tacrolimus: treatment failure in a patient with alopecia areata. 2000 Arch Dermatol pmid:10632221
Rotunda AM et al. Hyperkeratotic plaques on the palms and soles. Palmoplantar lichen planus, hyperkeratotic variant. 2004 Arch Dermatol pmid:15492196
Laffitte E and Panizzon RG Is topical tacrolimus really an effective therapy for Hailey-Hailey disease? 2004 Arch Dermatol pmid:15492199
Jegasothy BV et al. Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis. 1992 Arch Dermatol pmid:1376102
Van Leent EJ et al. Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. 1998 Arch Dermatol pmid:9681343
Choi CJ and Nghiem P Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients. 2001 Arch Dermatol pmid:11559218
Mandelin J et al. Effect of oral acetylsalicylic acid on burning caused by tacrolimus ointment in patients with atopic dermatitis. 2010 Arch Dermatol pmid:20956662
Lebwohl M et al. Proven efficacy of tacrolimus for facial and intertriginous psoriasis. 2005 Arch Dermatol pmid:16172314
Neill SM and Lewis FM Vulvovaginal lichen planus: a disease in need of a unified approach. 2008 Arch Dermatol pmid:19015426
Gorman CR and White SW Rosaceiform dermatitis as a complication of treatment of facial seborrheic dermatitis with 1% pimecrolimus cream. 2005 Arch Dermatol pmid:16172323
Cooper SM et al. Vulvovaginal lichen planus treatment: a survey of current practices. 2008 Arch Dermatol pmid:19015433
Heffernan MP et al. 0.1% tacrolimus ointment in the treatment of discoid lupus erythematosus. 2005 Arch Dermatol pmid:16172325
Lally A et al. Penile pyoderma gangrenosum treated with topical tacrolimus. 2005 Arch Dermatol pmid:16172330
Passeron T et al. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. 2004 Arch Dermatol pmid:15381545
Bunker CB et al. Topical tacrolimus, genital lichen sclerosus, and risk of squamous cell carcinoma. 2004 Arch Dermatol pmid:15381566
Le Cleach L et al. Is topical monotherapy effective for localized pyoderma gangrenosum? 2011 Arch Dermatol pmid:21242400
Ehst BD and Warshaw EM Alcohol-induced application site erythema after topical immunomodulator use and its inhibition by aspirin. 2004 Arch Dermatol pmid:15313828
Eiling E et al. Pimecrolimus: a novel treatment for cetuximab-induced papulopustular eruption. 2008 Arch Dermatol pmid:18794482
Byrd JA et al. Response of oral lichen planus to topical tacrolimus in 37 patients. 2004 Arch Dermatol pmid:15611431
Santos-Juanes J et al. Topical tacrolimus: an effective therapy for Zoon balanitis. 2004 Arch Dermatol pmid:15611442
Milingou M et al. Alcohol intolerance and facial flushing in patients treated with topical tacrolimus. 2004 Arch Dermatol pmid:15611445
Guenova E et al. Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab. 2011 Arch Dermatol pmid:21680759
Singh MN et al. Solitary cutaneous nodule in an immunocompromised patient. 2007 Arch Dermatol pmid:18087016
Ng W and Ikeda S Mount Tsukuba and the origin of tacrolimus. 2009 Arch Dermatol pmid:19289758
Sardana K et al. Effect of tacrolimus on vitiligo in absence of UV radiation exposure. 2007 Arch Dermatol pmid:17224558
Yan AC et al. The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study. 2010 Arch Dermatol pmid:20083693
Ciurea AM et al. Complete and durable clinical response of malignant pyoderma to tacrolimus in combination with dapsone and prednisone. 2010 Arch Dermatol pmid:20083712
Ward KM et al. Eyelash trichomegaly associated with systemic tacrolimus. 2006 Arch Dermatol pmid:16490862
Ostovari N et al. Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure. 2006 Arch Dermatol pmid:16490866
Mikhail M et al. Rapid enlargement of a malignant melanoma in a child with vitiligo vulgaris after application of topical tacrolimus. 2008 Arch Dermatol pmid:18427063
Chapman MS et al. 0.1% tacrolimus ointment for the treatment of intertrigo. 2005 Arch Dermatol pmid:15967933
Olivier V et al. Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study. 2002 Arch Dermatol pmid:12374539
Böhm M et al. Successful treatment of anogenital lichen sclerosus with topical tacrolimus. 2003 Arch Dermatol pmid:12873890
Reitamo S et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. 2000 Arch Dermatol pmid:10926735
Sugiura H et al. Long-term efficacy of tacrolimus ointment for recalcitrant facial erythema resistant to topical corticosteroids in adult patients with atopic dermatitis. 2000 Arch Dermatol pmid:10926750
Byrd JA et al. Recalcitrant symptomatic vulvar lichen planus: response to topical tacrolimus. 2004 Arch Dermatol pmid:15210463
Shah KN and Yan AC Low but detectable serum levels of tacrolimus seen with the use of very dilute, extemporaneously compounded formulations of tacrolimus ointment in the treatment of patients with netherton syndrome. 2006 Arch Dermatol pmid:17043199
Antille C et al. Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment. 2004 Arch Dermatol pmid:15096374
Passeron T et al. Treatment of oral erosive lichen planus with 1% pimecrolimus cream: a double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood. 2007 Arch Dermatol pmid:17438179
Bruce A and Rogers RS New and old therapeutics for oral ulcerations. 2007 Arch Dermatol pmid:17438186
Qureshi A and Fischer MA Topical calcineurin inhibitors revisited. 2007 Arch Dermatol pmid:17438195
Carroll PB et al. Effect of tacrolimus (FK506) in dystrophic epidermolysis bullosa: rationale and preliminary results. 1994 Arch Dermatol pmid:7526802
Cheng A and Mann C Oral erosive lichen planus treated with efalizumab. 2006 Arch Dermatol pmid:16785369
Sniezek PJ et al. Annular atrophic plaques on the arms of a 57-year-old woman. 2006 Arch Dermatol pmid:16785386
Allen DM and Esterly NB Significant systemic absorption of tacrolimus after topical application in a patient with lamellar ichthyosis. 2002 Arch Dermatol pmid:12225004
Hall VC et al. Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment. 2003 Arch Dermatol pmid:12925404